Zhejiang Orient Gene Biotech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.82%

Zhejiang Orient Gene Biotech Co Ltd (688298) has an Asset Resilience Ratio of 2.82% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Zhejiang Orient Gene Biotech Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥211.69 Million

≈ $30.98 Million USD Cash + Short-term Investments

Total Assets

CN¥7.51 Billion

≈ $1.10 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Zhejiang Orient Gene Biotech Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Orient Gene Biotech Co Ltd (688298) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Orient Gene Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Zhejiang Orient Gene Biotech Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥211.69 Million	2.82%
Total Liquid Assets	CN¥211.69 Million	2.82%

Asset Resilience Insights

Limited Liquidity: Zhejiang Orient Gene Biotech Co Ltd maintains only 2.82% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Orient Gene Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Orient Gene Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Shanghai MicroPort EV MedTech Co. Ltd. A SHG:688351	Medical Devices	49.23%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
Shenzhen Lifotronic Technology Co SHG:688389	Medical Devices	2.53%
Shanghai General Healthy Information and Technology Co. Ltd. SHG:605186	Medical Devices	0.84%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%

Annual Asset Resilience Ratio for Zhejiang Orient Gene Biotech Co Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Orient Gene Biotech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.56%	CN¥207.58 Million ≈ $30.38 Million	CN¥8.09 Billion ≈ $1.18 Billion	-9.13pp
2023-12-31	11.70%	CN¥1.05 Billion ≈ $153.98 Million	CN¥9.00 Billion ≈ $1.32 Billion	+0.85pp
2022-12-31	10.84%	CN¥1.16 Billion ≈ $169.84 Million	CN¥10.70 Billion ≈ $1.57 Billion	+8.97pp
2021-12-31	1.87%	CN¥168.07 Million ≈ $24.59 Million	CN¥8.98 Billion ≈ $1.31 Billion	-3.70pp
2020-12-31	5.57%	CN¥199.00 Million ≈ $29.12 Million	CN¥3.57 Billion ≈ $522.87 Million	--

pp = percentage points

About Zhejiang Orient Gene Biotech Co Ltd

SHG:688298 China Medical Devices

Market Cap

$567.59 Million

CN¥3.88 Billion CNY

Market Cap Rank

#11725 Global

#3385 in China

Share Price

CN¥19.24

Change (1 day)

-1.74%

52-Week Range

CN¥19.24 - CN¥29.94

All Time High

CN¥221.47